SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '3u24'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID
Hit
Macromolecule
Res.
Matches
Interface HETATM RMSD Dali
Z-score
Seq.
Identity (%)
View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1C6Y_B_MK1B524_1
(PROTEIN (PROTEASE))
3u24 PUTATIVE LIPOPROTEIN
(Shewanella
oneidensis)
6 / 11 ARG A 554
LEU A 567
VAL A 351
ILE A 430
GLY A 432
ILE A 356
None
1.18A 1c6yA-3u24A:
undetectable
1c6yA-3u24A:
11.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1HPV_B_478B200_1
(HIV-1 PROTEASE)
3u24 PUTATIVE LIPOPROTEIN
(Shewanella
oneidensis)
5 / 9 LEU A 567
VAL A 351
ILE A 430
GLY A 432
ILE A 356
None
1.01A 1hpvA-3u24A:
undetectable
1hpvA-3u24A:
11.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1HSG_B_MK1B902_1
(HIV-1 PROTEASE)
3u24 PUTATIVE LIPOPROTEIN
(Shewanella
oneidensis)
6 / 10 ARG A 554
LEU A 567
VAL A 351
ILE A 430
GLY A 432
ILE A 356
None
1.19A 1hsgA-3u24A:
undetectable
1hsgA-3u24A:
11.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1J36_A_LPRA801_1
(ANGIOTENSIN
CONVERTING ENZYME)
3u24 PUTATIVE LIPOPROTEIN
(Shewanella
oneidensis)
5 / 12 HIS A 427
GLU A 428
HIS A 433
GLU A 458
TYR A 543
ZN  A 595 (-3.1A)
ZN  A 595 ( 4.4A)
ZN  A 595 (-3.3A)
ZN  A 595 (-2.0A)
None
0.76A 1j36A-3u24A:
9.4
1j36A-3u24A:
22.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1J36_A_LPRA801_1
(ANGIOTENSIN
CONVERTING ENZYME)
3u24 PUTATIVE LIPOPROTEIN
(Shewanella
oneidensis)
5 / 12 HIS A 427
HIS A 433
GLU A 458
LYS A 529
TYR A 543
ZN  A 595 (-3.1A)
ZN  A 595 (-3.3A)
ZN  A 595 (-2.0A)
None
None
0.95A 1j36A-3u24A:
9.4
1j36A-3u24A:
22.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1J36_B_LPRB802_1
(ANGIOTENSIN
CONVERTING ENZYME)
3u24 PUTATIVE LIPOPROTEIN
(Shewanella
oneidensis)
5 / 12 HIS A 427
GLU A 428
HIS A 433
GLU A 458
TYR A 543
ZN  A 595 (-3.1A)
ZN  A 595 ( 4.4A)
ZN  A 595 (-3.3A)
ZN  A 595 (-2.0A)
None
0.76A 1j36B-3u24A:
9.3
1j36B-3u24A:
22.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1J36_B_LPRB802_1
(ANGIOTENSIN
CONVERTING ENZYME)
3u24 PUTATIVE LIPOPROTEIN
(Shewanella
oneidensis)
5 / 12 HIS A 427
HIS A 433
GLU A 458
LYS A 529
TYR A 543
ZN  A 595 (-3.1A)
ZN  A 595 (-3.3A)
ZN  A 595 (-2.0A)
None
None
0.96A 1j36B-3u24A:
9.3
1j36B-3u24A:
22.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1J37_A_X8ZA801_1
(ANGIOTENSIN
CONVERTING ENZYME)
3u24 PUTATIVE LIPOPROTEIN
(Shewanella
oneidensis)
6 / 11 HIS A 427
GLU A 428
HIS A 433
GLU A 458
LYS A 529
TYR A 543
ZN  A 595 (-3.1A)
ZN  A 595 ( 4.4A)
ZN  A 595 (-3.3A)
ZN  A 595 (-2.0A)
None
None
0.98A 1j37A-3u24A:
8.5
1j37A-3u24A:
22.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1J37_B_X8ZB802_1
(ANGIOTENSIN
CONVERTING ENZYME)
3u24 PUTATIVE LIPOPROTEIN
(Shewanella
oneidensis)
6 / 11 HIS A 427
GLU A 428
HIS A 433
GLU A 458
LYS A 529
TYR A 543
ZN  A 595 (-3.1A)
ZN  A 595 ( 4.4A)
ZN  A 595 (-3.3A)
ZN  A 595 (-2.0A)
None
None
0.99A 1j37B-3u24A:
8.6
1j37B-3u24A:
22.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1KIJ_A_NOVA400_2
(DNA GYRASE SUBUNIT B)
3u24 PUTATIVE LIPOPROTEIN
(Shewanella
oneidensis)
3 / 3 ASN A 195
PHE A 202
VAL A 140
None
None
EDO  A 600 (-4.7A)
0.64A 1kijA-3u24A:
undetectable
1kijA-3u24A:
21.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1KIJ_B_NOVB444_1
(DNA GYRASE SUBUNIT B)
3u24 PUTATIVE LIPOPROTEIN
(Shewanella
oneidensis)
5 / 12 ASN A 139
ILE A 169
PRO A 170
ILE A 234
ALA A 198
None
None
EDO  A 610 (-3.8A)
None
None
1.27A 1kijB-3u24A:
undetectable
1kijB-3u24A:
21.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1O86_A_LPRA702_1
(ANGIOTENSIN
CONVERTING ENZYME)
3u24 PUTATIVE LIPOPROTEIN
(Shewanella
oneidensis)
5 / 12 HIS A 427
GLU A 428
HIS A 433
GLU A 458
TYR A 543
ZN  A 595 (-3.1A)
ZN  A 595 ( 4.4A)
ZN  A 595 (-3.3A)
ZN  A 595 (-2.0A)
None
0.80A 1o86A-3u24A:
10.2
1o86A-3u24A:
22.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1O86_A_LPRA702_1
(ANGIOTENSIN
CONVERTING ENZYME)
3u24 PUTATIVE LIPOPROTEIN
(Shewanella
oneidensis)
5 / 12 HIS A 427
HIS A 433
GLU A 458
LYS A 529
TYR A 543
ZN  A 595 (-3.1A)
ZN  A 595 (-3.3A)
ZN  A 595 (-2.0A)
None
None
0.97A 1o86A-3u24A:
10.2
1o86A-3u24A:
22.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1TUV_A_VK3A4558_1
(PROTEIN YGIN)
3u24 PUTATIVE LIPOPROTEIN
(Shewanella
oneidensis)
4 / 7 TYR A 463
LEU A 575
MET A 589
ILE A 585
None
1.19A 1tuvA-3u24A:
undetectable
1tuvA-3u24A:
10.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1UDT_A_VIAA1000_1
(CGMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE)
3u24 PUTATIVE LIPOPROTEIN
(Shewanella
oneidensis)
5 / 12 ASN A 195
ALA A 175
ILE A  75
ALA A 233
MET A 166
None
None
CA  A 607 ( 4.8A)
None
None
1.32A 1udtA-3u24A:
undetectable
1udtA-3u24A:
21.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1XZX_X_T3X500_1
(THYROID HORMONE
RECEPTOR BETA-1)
3u24 PUTATIVE LIPOPROTEIN
(Shewanella
oneidensis)
5 / 12 ILE A 229
ALA A 233
LEU A  73
ILE A  75
PHE A 202
None
None
EDO  A 600 (-4.8A)
CA  A 607 ( 4.8A)
None
1.01A 1xzxX-3u24A:
undetectable
1xzxX-3u24A:
19.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1YA3_A_STRA1001_1
(MINERALOCORTICOID
RECEPTOR)
3u24 PUTATIVE LIPOPROTEIN
(Shewanella
oneidensis)
5 / 12 LEU A 241
ASN A 195
LEU A 193
LEU A 535
ARG A 531
None
1.16A 1ya3A-3u24A:
undetectable
1ya3A-3u24A:
19.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2A3A_A_TEPA1435_1
(CHITINASE)
3u24 PUTATIVE LIPOPROTEIN
(Shewanella
oneidensis)
3 / 3 TRP A 419
GLU A 479
TYR A 306
None
1.21A 2a3aA-3u24A:
undetectable
2a3aA-3u24A:
20.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2C6N_A_LPRA705_1
(ANGIOTENSIN-CONVERTI
NG ENZYME, SOMATIC
ISOFORM)
3u24 PUTATIVE LIPOPROTEIN
(Shewanella
oneidensis)
5 / 12 HIS A 427
GLU A 428
HIS A 433
GLU A 458
TYR A 543
ZN  A 595 (-3.1A)
ZN  A 595 ( 4.4A)
ZN  A 595 (-3.3A)
ZN  A 595 (-2.0A)
None
0.76A 2c6nA-3u24A:
4.0
2c6nA-3u24A:
22.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2C6N_A_LPRA705_1
(ANGIOTENSIN-CONVERTI
NG ENZYME, SOMATIC
ISOFORM)
3u24 PUTATIVE LIPOPROTEIN
(Shewanella
oneidensis)
5 / 12 HIS A 427
HIS A 433
GLU A 458
LYS A 529
TYR A 543
ZN  A 595 (-3.1A)
ZN  A 595 (-3.3A)
ZN  A 595 (-2.0A)
None
None
0.92A 2c6nA-3u24A:
4.0
2c6nA-3u24A:
22.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2C6N_B_LPRB705_1
(ANGIOTENSIN-CONVERTI
NG ENZYME, SOMATIC
ISOFORM)
3u24 PUTATIVE LIPOPROTEIN
(Shewanella
oneidensis)
5 / 12 HIS A 427
GLU A 428
HIS A 433
GLU A 458
TYR A 543
ZN  A 595 (-3.1A)
ZN  A 595 ( 4.4A)
ZN  A 595 (-3.3A)
ZN  A 595 (-2.0A)
None
0.80A 2c6nB-3u24A:
8.6
2c6nB-3u24A:
22.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2C6N_B_LPRB705_1
(ANGIOTENSIN-CONVERTI
NG ENZYME, SOMATIC
ISOFORM)
3u24 PUTATIVE LIPOPROTEIN
(Shewanella
oneidensis)
5 / 12 HIS A 427
HIS A 433
GLU A 458
LYS A 529
TYR A 543
ZN  A 595 (-3.1A)
ZN  A 595 (-3.3A)
ZN  A 595 (-2.0A)
None
None
0.91A 2c6nB-3u24A:
8.6
2c6nB-3u24A:
22.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2H79_A_T3A1_1
(THRA PROTEIN)
3u24 PUTATIVE LIPOPROTEIN
(Shewanella
oneidensis)
5 / 12 ILE A 229
ALA A 233
LEU A  73
ILE A  75
PHE A 202
None
None
EDO  A 600 (-4.8A)
CA  A 607 ( 4.8A)
None
0.98A 2h79A-3u24A:
undetectable
2h79A-3u24A:
18.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2OKC_B_SAMB500_0
(TYPE I RESTRICTION
ENZYME STYSJI M
PROTEIN)
3u24 PUTATIVE LIPOPROTEIN
(Shewanella
oneidensis)
5 / 12 TYR A 547
ILE A 585
ALA A 455
GLY A 459
VAL A 462
None
1.19A 2okcB-3u24A:
undetectable
2okcB-3u24A:
22.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2Q64_B_1UNB1001_3
(PROTEASE RETROPEPSIN)
3u24 PUTATIVE LIPOPROTEIN
(Shewanella
oneidensis)
6 / 12 ARG A 554
LEU A 567
VAL A 351
ILE A 430
GLY A 432
ILE A 356
None
1.29A 2q64B-3u24A:
undetectable
2q64B-3u24A:
11.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2R5P_B_MK1B902_1
(PROTEASE)
3u24 PUTATIVE LIPOPROTEIN
(Shewanella
oneidensis)
6 / 12 ARG A 554
LEU A 567
VAL A 351
ILE A 430
GLY A 432
ILE A 356
None
1.30A 2r5pA-3u24A:
undetectable
2r5pA-3u24A:
12.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2R5P_D_MK1D902_1
(PROTEASE)
3u24 PUTATIVE LIPOPROTEIN
(Shewanella
oneidensis)
6 / 12 ARG A 554
LEU A 567
VAL A 351
ILE A 430
GLY A 432
ILE A 356
None
1.30A 2r5pC-3u24A:
undetectable
2r5pC-3u24A:
12.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2X8Z_A_X8ZA1615_1
(ANGIOTENSIN
CONVERTING ENZYME)
3u24 PUTATIVE LIPOPROTEIN
(Shewanella
oneidensis)
5 / 11 HIS A 427
GLU A 428
HIS A 433
GLU A 458
TYR A 543
ZN  A 595 (-3.1A)
ZN  A 595 ( 4.4A)
ZN  A 595 (-3.3A)
ZN  A 595 (-2.0A)
None
0.77A 2x8zA-3u24A:
2.4
2x8zA-3u24A:
22.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2X8Z_A_X8ZA1615_1
(ANGIOTENSIN
CONVERTING ENZYME)
3u24 PUTATIVE LIPOPROTEIN
(Shewanella
oneidensis)
5 / 11 HIS A 427
HIS A 433
GLU A 458
LYS A 529
TYR A 543
ZN  A 595 (-3.1A)
ZN  A 595 (-3.3A)
ZN  A 595 (-2.0A)
None
None
0.92A 2x8zA-3u24A:
2.4
2x8zA-3u24A:
22.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2X91_A_LPRA1615_1
(ANGIOTENSIN
CONVERTING ENZYME)
3u24 PUTATIVE LIPOPROTEIN
(Shewanella
oneidensis)
5 / 12 HIS A 427
GLU A 428
HIS A 433
GLU A 458
TYR A 543
ZN  A 595 (-3.1A)
ZN  A 595 ( 4.4A)
ZN  A 595 (-3.3A)
ZN  A 595 (-2.0A)
None
0.80A 2x91A-3u24A:
9.5
2x91A-3u24A:
22.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2X91_A_LPRA1615_1
(ANGIOTENSIN
CONVERTING ENZYME)
3u24 PUTATIVE LIPOPROTEIN
(Shewanella
oneidensis)
5 / 12 HIS A 427
HIS A 433
GLU A 458
LYS A 529
TYR A 543
ZN  A 595 (-3.1A)
ZN  A 595 (-3.3A)
ZN  A 595 (-2.0A)
None
None
0.98A 2x91A-3u24A:
9.5
2x91A-3u24A:
22.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3BVB_B_017B401_1
(PROTEASE
(RETROPEPSIN))
3u24 PUTATIVE LIPOPROTEIN
(Shewanella
oneidensis)
6 / 12 ARG A 554
LEU A 567
VAL A 351
ILE A 430
GLY A 432
ILE A 356
None
1.31A 3bvbA-3u24A:
undetectable
3bvbA-3u24A:
11.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3EKQ_A_ROCA100_2
(PROTEASE)
3u24 PUTATIVE LIPOPROTEIN
(Shewanella
oneidensis)
5 / 9 LEU A 567
VAL A 351
ILE A 430
GLY A 432
ILE A 356
None
1.05A 3ekqB-3u24A:
undetectable
3ekqB-3u24A:
11.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3EM6_A_017A200_2
(PROTEASE)
3u24 PUTATIVE LIPOPROTEIN
(Shewanella
oneidensis)
6 / 12 ARG A 554
LEU A 567
VAL A 351
ILE A 430
GLY A 432
ILE A 356
None
1.30A 3em6B-3u24A:
undetectable
3em6B-3u24A:
11.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3GWS_X_T3X500_1
(THYROID HORMONE
RECEPTOR BETA)
3u24 PUTATIVE LIPOPROTEIN
(Shewanella
oneidensis)
5 / 12 ILE A 229
ALA A 233
ALA A 171
ILE A  75
PHE A 202
None
None
EDO  A 610 (-3.4A)
CA  A 607 ( 4.8A)
None
1.07A 3gwsX-3u24A:
undetectable
3gwsX-3u24A:
18.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3GWS_X_T3X500_1
(THYROID HORMONE
RECEPTOR BETA)
3u24 PUTATIVE LIPOPROTEIN
(Shewanella
oneidensis)
5 / 12 ILE A 229
ALA A 233
LEU A  73
ILE A  75
PHE A 202
None
None
EDO  A 600 (-4.8A)
CA  A 607 ( 4.8A)
None
1.02A 3gwsX-3u24A:
undetectable
3gwsX-3u24A:
18.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3MDT_A_VORA506_1
(CHOLESTEROL
24-HYDROXYLASE)
3u24 PUTATIVE LIPOPROTEIN
(Shewanella
oneidensis)
5 / 9 LEU A 241
SER A 239
ILE A 234
ALA A 233
ALA A 174
None
1.29A 3mdtA-3u24A:
undetectable
3mdtA-3u24A:
22.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NU5_B_478B401_2
(PROTEASE)
3u24 PUTATIVE LIPOPROTEIN
(Shewanella
oneidensis)
6 / 12 ARG A 554
LEU A 567
VAL A 351
ILE A 430
GLY A 432
ILE A 356
None
1.29A 3nu5B-3u24A:
undetectable
3nu5B-3u24A:
11.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4C2P_A_X8ZA709_1
(ANGIOTENSIN-CONVERTI
NG ENZYME)
3u24 PUTATIVE LIPOPROTEIN
(Shewanella
oneidensis)
6 / 11 HIS A 427
GLU A 428
HIS A 433
GLU A 458
LYS A 529
TYR A 543
ZN  A 595 (-3.1A)
ZN  A 595 ( 4.4A)
ZN  A 595 (-3.3A)
ZN  A 595 (-2.0A)
None
None
0.86A 4c2pA-3u24A:
11.3
4c2pA-3u24A:
22.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4C5L_A_UEGA300_1
(PHOSPHOMETHYLPYRIMID
INE KINASE)
3u24 PUTATIVE LIPOPROTEIN
(Shewanella
oneidensis)
5 / 11 GLY A 546
ALA A 461
GLY A 459
VAL A 491
HIS A 433
None
ZN  A 595 ( 4.2A)
None
None
ZN  A 595 (-3.3A)
1.12A 4c5lA-3u24A:
undetectable
4c5lA-3u24A:
18.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4C5L_B_PXLB300_1
(PHOSPHOMETHYLPYRIMID
INE KINASE)
3u24 PUTATIVE LIPOPROTEIN
(Shewanella
oneidensis)
5 / 9 GLY A 546
ALA A 461
GLY A 459
VAL A 491
HIS A 433
None
ZN  A 595 ( 4.2A)
None
None
ZN  A 595 (-3.3A)
1.12A 4c5lB-3u24A:
undetectable
4c5lB-3u24A:
18.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4C5L_C_UEGC300_1
(PHOSPHOMETHYLPYRIMID
INE KINASE)
3u24 PUTATIVE LIPOPROTEIN
(Shewanella
oneidensis)
5 / 10 GLY A 546
ALA A 461
GLY A 459
VAL A 491
HIS A 433
None
ZN  A 595 ( 4.2A)
None
None
ZN  A 595 (-3.3A)
1.10A 4c5lC-3u24A:
undetectable
4c5lC-3u24A:
18.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4C5L_D_UEGD300_1
(PHOSPHOMETHYLPYRIMID
INE KINASE)
3u24 PUTATIVE LIPOPROTEIN
(Shewanella
oneidensis)
5 / 10 GLY A 546
ALA A 461
GLY A 459
VAL A 491
HIS A 433
None
ZN  A 595 ( 4.2A)
None
None
ZN  A 595 (-3.3A)
1.12A 4c5lD-3u24A:
undetectable
4c5lD-3u24A:
18.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4C5N_B_PXLB300_1
(PHOSPHOMETHYLPYRIMID
INE KINASE)
3u24 PUTATIVE LIPOPROTEIN
(Shewanella
oneidensis)
5 / 10 GLY A 546
ALA A 461
GLY A 459
VAL A 491
HIS A 433
None
ZN  A 595 ( 4.2A)
None
None
ZN  A 595 (-3.3A)
1.09A 4c5nB-3u24A:
undetectable
4c5nB-3u24A:
18.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4C5N_D_UEGD300_1
(PHOSPHOMETHYLPYRIMID
INE KINASE)
3u24 PUTATIVE LIPOPROTEIN
(Shewanella
oneidensis)
5 / 10 GLY A 546
ALA A 461
GLY A 459
VAL A 491
HIS A 433
None
ZN  A 595 ( 4.2A)
None
None
ZN  A 595 (-3.3A)
1.06A 4c5nD-3u24A:
undetectable
4c5nD-3u24A:
18.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DQB_B_017B101_1
(ASPARTYL PROTEASE)
3u24 PUTATIVE LIPOPROTEIN
(Shewanella
oneidensis)
6 / 12 ARG A 554
LEU A 567
VAL A 351
ILE A 430
GLY A 432
ILE A 356
None
1.25A 4dqbA-3u24A:
undetectable
4dqbA-3u24A:
11.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DQF_B_017B101_1
(ASPARTYL PROTEASE)
3u24 PUTATIVE LIPOPROTEIN
(Shewanella
oneidensis)
6 / 12 ARG A 554
LEU A 567
VAL A 351
ILE A 430
GLY A 432
ILE A 356
None
1.37A 4dqfA-3u24A:
undetectable
4dqfA-3u24A:
11.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4FFW_B_715B801_1
(DIPEPTIDYL PEPTIDASE
4)
3u24 PUTATIVE LIPOPROTEIN
(Shewanella
oneidensis)
5 / 12 GLY A 472
TYR A 547
VAL A 291
TYR A 485
TYR A 484
None
1.30A 4ffwB-3u24A:
undetectable
4ffwB-3u24A:
21.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4X5I_A_FOLA201_1
(DIHYDROFOLATE
REDUCTASE)
3u24 PUTATIVE LIPOPROTEIN
(Shewanella
oneidensis)
3 / 3 ASP A 289
ARG A 466
ARG A 548
ZN  A   5 (-2.2A)
None
None
0.93A 4x5iA-3u24A:
undetectable
4x5iA-3u24A:
13.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4Y4D_A_CFFA411_1
(ENDOTHIAPEPSIN)
3u24 PUTATIVE LIPOPROTEIN
(Shewanella
oneidensis)
4 / 6 LEU A  62
LEU A  73
ILE A 148
PHE A 144
None
EDO  A 600 (-4.8A)
None
None
1.06A 4y4dA-3u24A:
undetectable
4y4dA-3u24A:
20.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EAJ_B_FOLB201_1
(DIHYDROFOLATE
REDUCTASE)
3u24 PUTATIVE LIPOPROTEIN
(Shewanella
oneidensis)
3 / 3 ASP A 289
ARG A 466
ARG A 548
ZN  A   5 (-2.2A)
None
None
0.94A 5eajB-3u24A:
undetectable
5eajB-3u24A:
14.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5KQX_A_ROCA101_2
(PROTEASE E35D-SQV)
3u24 PUTATIVE LIPOPROTEIN
(Shewanella
oneidensis)
5 / 9 LEU A 567
VAL A 351
ILE A 430
GLY A 432
ILE A 356
None
1.13A 5kqxB-3u24A:
undetectable
5kqxB-3u24A:
11.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5KQY_B_017B101_1
(PROTEASE E35D-DRV)
3u24 PUTATIVE LIPOPROTEIN
(Shewanella
oneidensis)
5 / 12 LEU A 567
VAL A 351
ILE A 430
GLY A 432
ILE A 356
None
1.14A 5kqyA-3u24A:
undetectable
5kqyA-3u24A:
11.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6I0Y_A_TRPA3001_0
(23S RIBOSOMAL RNA
TRYPTOPHANASE OPERON
LEADER PEPTIDE)
3u24 PUTATIVE LIPOPROTEIN
(Shewanella
oneidensis)
3 / 3 TRP A 123
ILE A 125
ASP A 124
None
None
ACY  A 599 (-2.4A)
0.76A 6i0y7-3u24A:
undetectable
6i0y7-3u24A:
3.56